Go to
www.dh.gov.uk/en/Consultations/Liveconsultations/DH_120834
The closing date is mid January 2011
I presume we need to safeguard our position in the event that the NICE final guidance on dasatinib and nilotinib is not in our favour?
The fund of £200m I guess will soon be shown to be inadequate given the demand from those with all forms of cancer treatments that currently some PCTs will not fund
Will this support group be invited to contribute on the basis of being a major stakeholder or do we need to go ahead with representations anyway?
Best wishes
John